These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. Celum CL; Robinson NJ; Cohen MS J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220 [TBL] [Abstract][Full Text] [Related]
5. Recent developments in the management of herpes simplex virus infection in HIV-infected persons. Bartlett JG Clin Infect Dis; 2004 Nov; 39 Suppl 5():S237-9. PubMed ID: 15494894 [No Abstract] [Full Text] [Related]
6. HIV/AIDS. At last, vaginal gel scores victory against HIV. Cohen J Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914 [No Abstract] [Full Text] [Related]
7. Trio of studies makes headway in HIV battle. Check E Nature; 2007 Mar; 446(7131):12. PubMed ID: 17330014 [No Abstract] [Full Text] [Related]
8. HSV-2 suppression and the incidence of HIV. Lisco A; Vanpouille C N Engl J Med; 2008 Jul; 359(5):535; author reply 535. PubMed ID: 18669436 [No Abstract] [Full Text] [Related]
9. Effect of aciclovir on HIV-1 acquisition in HSV-2-positive patients. Hudson CP Lancet; 2008 Oct; 372(9646):1298; author reply 1298-9. PubMed ID: 18929897 [No Abstract] [Full Text] [Related]
10. Treatment of genital herpes infections in HIV-infected patients. Foley E; Patel R J HIV Ther; 2004 Feb; 9(1):14-8. PubMed ID: 15071425 [TBL] [Abstract][Full Text] [Related]
11. Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”. Cohen MS; Eron JJ Sex Transm Dis; 2011 May; 38(5):410-2. PubMed ID: 22256341 [No Abstract] [Full Text] [Related]
12. Synergistic copathogens--HIV-1 and HSV-2. Corey L N Engl J Med; 2007 Feb; 356(8):854-6. PubMed ID: 17314346 [No Abstract] [Full Text] [Related]
13. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. Gray R; Wilson D N Engl J Med; 2010 May; 362(18):1740; author reply 1741-2. PubMed ID: 20445189 [No Abstract] [Full Text] [Related]
14. Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2. Reynolds SJ; Quinn TC Infect Dis Clin North Am; 2005 Jun; 19(2):415-25. PubMed ID: 15963880 [TBL] [Abstract][Full Text] [Related]
16. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; MacQueen KM Sex Transm Dis; 2008 Dec; 35(12):1002-8. PubMed ID: 19051397 [TBL] [Abstract][Full Text] [Related]
17. Pre-exposure prophylaxis effective. AIDS Patient Care STDS; 2006 Sep; 20(9):660. PubMed ID: 17036415 [No Abstract] [Full Text] [Related]
18. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention. Thurman AR; Doncel GF Int J STD AIDS; 2012 Sep; 23(9):613-9. PubMed ID: 23033511 [TBL] [Abstract][Full Text] [Related]
19. Reassessing the hypothesis on STI control for HIV prevention. Gray RH; Wawer MJ Lancet; 2008 Jun; 371(9630):2064-5. PubMed ID: 18572064 [No Abstract] [Full Text] [Related]
20. Adherence in HIV type 1 prevention trials. Baeten JM J Infect Dis; 2010 May; 201(9):1279-81. PubMed ID: 20235837 [No Abstract] [Full Text] [Related] [Next] [New Search]